Literature DB >> 8238864

Oligosaccharide composition of heparin and low-molecular-weight heparins by capillary electrophoresis.

U R Desai1, H Wang, S A Ampofo, R J Linhardt.   

Abstract

The application of capillary electrophoresis to total compositional analysis of heparin and low-molecular-weight heparin samples has been studied. Optimum resolution of 17 defined oligosaccharides was obtained with the buffer system composed of 10 mM sodium borate and 50 mM sodium dodecyl sulfate at pH 8.81 and at a constant voltage of 20 kV. The ratio of oligosaccharide charge to the number of saccharide residues correlated with the migration time. For oligosaccharides having the same charge to saccharide ratio, the larger of the oligosaccharides eluted earlier. A hexasaccharide having a 3-O-sulfated glucosamine residue at the reducing end and arising from heparin's antithrombin III binding site, migrated in an unusual fashion. The limit of oligosaccharide detection was from 600 fmol to 1 pmol. Quantitative analysis could conveniently be performed on 10 pmol of an oligosaccharide sample. Oligosaccharide composition using capillary electrophoresis was obtained by nearly complete depolymerization of heparins with a mixture of heparin lyase I, II, and III. The analysis resulted in 95% mass balance for both heparin and low-molecular-weight heparin. Capillary electropherograms of heparin and different low-molecular-weight heparins depolymerized with heparin lyase I alone showed a high level of structural heterogeneity in the products formed. The oligosaccharide maps thus obtained might find use in fingerprinting the heparin and low-molecular-weight samples.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8238864     DOI: 10.1006/abio.1993.1394

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  13 in total

1.  Heparin sequencing brings structure to the function of complex oligosaccharides.

Authors:  M A Nugent
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

2.  Competitive inhibition of heparinase by persulfonated glycosaminoglycans: a tool to detect heparin contamination.

Authors:  Udayanath Aich; Zachary Shriver; Kannan Tharakaraman; Rahul Raman; Ram Sasisekharan
Journal:  Anal Chem       Date:  2011-09-19       Impact factor: 6.986

3.  Analysis of glycosaminoglycan-derived disaccharides by capillary electrophoresis using laser-induced fluorescence detection.

Authors:  Yuqing Chang; Bo Yang; Xue Zhao; Robert J Linhardt
Journal:  Anal Biochem       Date:  2012-05-15       Impact factor: 3.365

Review 4.  Hyphenated techniques for the analysis of heparin and heparan sulfate.

Authors:  Bo Yang; Kemal Solakyildirim; Yuqing Chang; Robert J Linhardt
Journal:  Anal Bioanal Chem       Date:  2010-09-19       Impact factor: 4.142

5.  A strategy for rapid sequencing of heparan sulfate and heparin saccharides.

Authors:  J E Turnbull; J J Hopwood; J T Gallagher
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

6.  Assignment Of Hexuronic Acid Stereochemistry In Synthetic Heparan Sulfate Tetrasaccharides With 2-O-Sulfo Uronic Acids Using Electron Detachment Dissociation.

Authors:  Isaac Agyekum; Anish B Patel; Chengli Zong; Geert-Jan Boons; Jonathan Amster
Journal:  Int J Mass Spectrom       Date:  2015-11-15       Impact factor: 1.986

Review 7.  The structural elucidation of glycosaminoglycans.

Authors:  Vikas Prabhakar; Ishan Capila; Ram Sasisekharan
Journal:  Methods Mol Biol       Date:  2009

8.  Purification, characterization and specificity of chondroitin lyases and glycuronidase from Flavobacterium heparinum.

Authors:  K Gu; R J Linhardt; M Laliberté; K Gu; J Zimmermann
Journal:  Biochem J       Date:  1995-12-01       Impact factor: 3.857

Review 9.  Capillary electrophoresis of complex natural polysaccharides.

Authors:  Nicola Volpi; Francesca Maccari; Robert J Linhardt
Journal:  Electrophoresis       Date:  2008-08       Impact factor: 3.535

10.  Oversulfated chondroitin sulfate: impact of a heparin impurity, associated with adverse clinical events, on low-molecular-weight heparin preparation.

Authors:  Zhenqing Zhang; Michel Weïwer; Boyangzi Li; Melissa M Kemp; Tyler H Daman; Robert J Linhardt
Journal:  J Med Chem       Date:  2008-09-25       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.